Charles River Laboratories International (CRL) reported $4.0B in revenue for fiscal 2025, −0.9% year on year. That ranks #929 by revenue among 2853 SEC filers and #82 in Healthcare. It posted a net loss of −$144M for the same year. Revenue has grown 10.2% a year on average since 2012 ($1.1B then). The fiscal 2025 balance sheet shows $7.1B in total assets, $214M in cash and $2.1B in long-term debt.
Key figures
| Key figures | FY2025 | YoY | Source |
|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $4.0B | −0.9% | FY20252025-12-27 |
| Gross profit | Not reported | — | |
| Operating incomeOperatingIncomeLoss | $25.2M | −88.9% | FY20252025-12-27 |
| Net incomeNetIncomeLoss | −$144M | −$167M | FY20252025-12-27 |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $738M | +0.4% | FY20252025-12-27 |
| Capital expenditurePaymentsToAcquireProductiveAssets | $219M | −5.9% | FY20252025-12-27 |
| Total assetsAssets | $7.1B | −5.2% | FY20252025-12-27 |
| Shareholders' equityStockholdersEquity | $3.2B | −8.6% | FY20252025-12-27 |
| CashCashAndCashEquivalentsAtCarryingValue | $214M | +9.8% | FY20252025-12-27 |
| Long-term debtLongTermDebtAndCapitalLeaseObligations | $2.1B | −4.6% | FY20252025-12-27 |
Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Reported since the last full year
Three-month figures this company has filed since FY2025. A quarter is not comparable with a full year, and these figures are used nowhere else on the site: not in any ranking, not in comparisons, not in the download.
| Quarter | Revenue | Net income | Source |
|---|---|---|---|
| Q1 20262026-03-28 | $996M | −$14.8M | Open → |
| Q2 20262026-06-27 | $1.0B | −$1.5M | Open → |
Only periods that end on a calendar quarter appear here. A company whose fiscal year ends in June files on a different calendar, so it has no row.
Where this sits in its sector
Each bar is the spread of the whole sector: the box covers the middle half of companies, the line inside it the median, and the triangle this company. The axis is clipped at the 5th and 95th percentile so a single outlier does not flatten it.
| Where this sits in its sector | FY2025 | Position in sector |
|---|---|---|
| Net marginRank 129 of 161 companies compared | −3.6% | |
| Operating marginRank 130 of 160 companies compared | 0.6% | |
| Cash as share of revenueRank 120 of 160 companies compared | 5.3% |
All four are ratios derived from two reported lines, not single filing items. Peer group: companies in the same sector with revenue of $1bn or more; loss-making companies are included.
Profile
- Legal name
- Charles River Laboratories International, Inc.
- Ticker
- CRL
- Exchange
- NYSE
- SIC classification
- Services-Commercial Physical & Biological Research (8731)
- Fiscal year end
- 12-27
- CIK
- 0001100682
Filings
- 10-QAug 5, 2026Open filing →
- 10-QMay 7, 2026Open filing →
- 10-KFeb 18, 2026Open filing →
Similar in size, same sector
| Company | Revenue | Net income |
|---|---|---|
| PerrigoPRGO | $4.3B | −$1.4B |
| Cooper CompaniesCOO | $4.1B | $375M |
| Align TechnologyALGN | $4.0B | $410M |
| Charles River Laboratories InternationalCRL | $4.0B | −$144M |
| Alignment HealthcareALHC | $3.9B | −$724,000 |
| GenmabGMAB | $3.7B | $963M |
| Alnylam PharmaceuticalsALNY | $3.7B | $314M |
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Charles River Laboratories International — Key figures |url=https://companiesranked.com/en/company/charles-river-laboratories-international |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Charles River Laboratories International — Key figures. CompaniesRanked. https://companiesranked.com/en/company/charles-river-laboratories-internationalBibTeX
@misc{companiesranked-en-company-charles-river-laboratories-international-2026,
author = {{CompaniesRanked}},
title = {{Charles River Laboratories International — Key figures}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/charles-river-laboratories-international}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001100682-26-000022 · February 18, 2026
{{cite web |title=Charles River Laboratories International — Key figures — 10-K (0001100682-26-000022) |url=https://www.sec.gov/Archives/edgar/data/1100682/000110068226000022/crl-20251227.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-18}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.